Lenacapavir

Unassigned

New Medicines

HIV infection

Information

New molecular entity
Gilead Sciences
Gilead Sciences

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

A long-acting HIV capsid inhibitor
In 2013, a total of 6,000 persons (4,500 men and 1,500 women) were newly diagnosed with HIV in the UK. The number of newly diagnosed heterosexual men and women has dropped over the years from 4,890 in 2004 to 2,490 in 2013) due to fewer diagnoses among people born in sub-Saharan Africa [1].
HIV infection
Oral